Alpha DNA Investment Management’s iShares MSCI EAFE Growth ETF EFG Stock Holding History
Bought
Maintained
Sold
Other funds holding EFG
PAS
Alpha DNA Investment Management's EFG Position: Q1 2022 in Review
Alpha DNA Investment Management sold out of iShares MSCI EAFE Growth ETF (EFG) in Q1 2022, closing a stake of 1,938 shares — an estimated $213K sold.
Alpha DNA Investment Management first reported a position in EFG in Q4 2020 and held it in 3 quarters. The position peaked at $213K in Q4 2021. 718 funds tracked by Wall St. Rank hold EFG as of Q1 2022.
- Alpha DNA Investment Management reported no remaining iShares MSCI EAFE Growth ETF position as of Q1 2022 after selling out during the quarter.
- Alpha DNA Investment Management sold 1,938 iShares MSCI EAFE Growth ETF shares in Q1 2022, an estimated $213K.
- Alpha DNA Investment Management first reported a position in iShares MSCI EAFE Growth ETF in Q4 2020 and held it in 3 quarters.
- Alpha DNA Investment Management's iShares MSCI EAFE Growth ETF position peaked at $213K in Q4 2021.
- 718 funds tracked by Wall St. Rank held iShares MSCI EAFE Growth ETF as of Q1 2022.
Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.